Clinical Trial Update: Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cariprazine (oral capsules or solution) in children and adolescents aged 5-17 with Autism Spectrum Disorder to assess adverse events …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: AbbVie | Conditions: Autism Spectrum Disorder | Phase 3 | Status: COMPLETED